In Brief: Royce Labs
Executive Summary
Royce Labs: Company and CEO Patrick McEnany enter settlement with the SEC resolving an investigation into Royce's disclosure between July 1991 and April 1992 regarding the status of its ANDAs for piroxicam and minoxidil and on sales of company securities during that time. Royce and McEnany consented to a civil injunction requiring them to comply with securities laws in the future. McEnany paid a $25,000 administrative fine that was reimbursed to him by the company...